3rd Annual ECD Medical Symposium Houston, TX
Symposium Summary
Approximately 52 medical professionals from eight countries attended the Annual ECD Medical Symposium in 2015. Twelve oral abstracts were presented. As an invited speakers, Omar Abdel-Wahab, MD, PhD, delivered a talk titled “Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms” and Timothy Craig Allen, MD, JD presented “Social Media in the Rare Disease World.” An evening reception provided time for discussions supporting current and future collaborations among this highly knowledgeable group of physicians and scientists, all interested in learning more about Erdheim-Chester Disease.
Programs with Symposium Agenda
Presentations
| Presenter | Presentation Slides | English Video |
|---|---|---|
| Filip Janku, MD PhD | Opening/Welcome/Introduction | No Video available |
| Omar Abdel-Wahab, MD, PhD | Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms | No Video available |
| Lorenzo Dagna, MD, Marina Ferrarini, MD | Tocilizumab for ECD | No Video available |
| Julien Haroche, MD, PhD, Zahir Amoura, MD | BRAF inhibitors in ECD ad overlap histiocytoses, an update 2015 | No Video available |
| Irina Eberle-Ayres, Stephen Cutler, PhD, David Bell, MSc, PhD | Targeted Delivery of Hemoglobin-Cladribine Conjugate Inhibits Proliferation of Cells Originating from Human Histiocytic Lymphomas | No Video available |
| Roei Mazor, MD | Analysis of the neuro-radiological phenotypes, objective CNS responses to treatment and the long-term neuroradiological evolution of the ECD | No Video available |
| Thomas Colby, MD | Does the absence of classic histology exclude ECD? | No Video available |
| Filip Janku, MD PhD | Low –frequency KRAS mutations in patients with BRAF-mutated ECD | No Video available |
| Adrianna Muniz, PhD, Mark Erlander, PhD | CLIA laboratory testing of urinary BRAF V600E DNA mutations: application in the management of patients with histiocytic disease | No Video available |
| Susan Robertson, PhD | Accepting Illness When Loss of Function is Permanent: A Model of Functional Adaptation | No Video available |
| Juvianee Estrada-Veras, MD, Pamela Gardner, DMD | Oral manifestation of ECD | No Video available |
| Juvianee Estrada-Veras, MD, William Gahl, MD, PhD | Cardiac health in ECD | No Video available |
| Eli Diamond, MD | Diffuse reduction of cerebral grey matter volumes in ECD | No Video available |
| Eli Diamond, MD, Filip Janku, MD, PhD, Juvianee I. Estrada-Veras, MD, Augusto Vaglio, MD, PhD, Lorenzo Dagna, MD | Panel discussion: Clinical Trials in ECD | No Video available |
| Timothy Craig Allen, MD, JD | Social Media in the Rare Disease World | No Video available |
| Filip Janku, MD, PhD, Kathleen Brewer | Symposium Conclusion | No Video available |